Today is #RareDiseaseDay! To show our support, we participated in National Organization for Rare Disorders' #LightUpForRare campaign and asked our colleagues worldwide to collectively light up for the millions of people who live with a #raredisease. Kyowa Kirin is united in our commitment to delivering for the rare disease community. We refuse to stand still in our mission to make more people smile. #KKIMakingPeopleSmile #RareDiseaseDay
Kyowa Kirin, Inc.- U.S.
制药业
Princeton，New Jersey 32,296 位关注者
Kyowa Kirin North America is a specialty pharmaceutical company dedicated to making a profound impact on patient lives.
关于我们
Kyowa Kirin is a global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines. We work on some of the hardest to treat diseases where need is high, and potential for life-changing impact is possible. The North America organization includes offices in Princeton, NJ; Toronto, Canada and a research facility in La Jolla, CA. Together, we work as a collaborative team to understand clinical needs and advance innovations that have a profound impact on patient lives. Our growth in North America relies on entrepreneurial team players who are willing to share their expertise and ideas in an environment that prioritizes innovation, diversity, integrity and “wa.” Each person plays a significant role in shaping the work we do and the results we deliver.
- 网站
-
https://kkna.kyowakirin.com/
Kyowa Kirin, Inc.- U.S.的外部链接
- 所属行业
- 制药业
- 规模
- 501-1,000 人
- 总部
- Princeton，New Jersey
- 类型
- 上市公司
- 领域
- Oncology、Oncology Supportive Care、Immunotherapy、Parkinson's Disease、Central Nervous System、Neurology、Hematology、biotechnology、antibodies、drug discovery、clinical development、Rare Disease、Pharmaceuticals、Specialty Pharmaceuticals、Patients、Pharmaceutical、Medicine、Movement Disorders、Specialty Care和gene therapy
地点
Kyowa Kirin, Inc.- U.S.员工
-
Shawn Masterson
-
John Spera
Transformative Senior Commercial Executive in BioPharma Start-Ups & Established businesses across Rare Disease, Digital Health and Medical Device
-
Michelle Rae Carlson
VP, Global Development Project Management, Kyowa Kirin, Inc.
-
Daniel Izzo
Biopharma Leader, Finance / Operations / Business Development / Alliance Management
动态
-
In honor of Rare Disease Month, Kyowa Kirin was delighted to host Dr. Al Freedman, a psychologist who focuses on #raredisease counseling, at a Munch and Learn event for employees entitled “Coping with the Challenges of Rare Disease: 25 Years of Lessons Learned.” During the presentation, Dr. Freedman relayed that receiving a rare disease diagnosis for many is a traumatic experience, but that scientific progress, resilience, community, compassion, and love are essential in navigating the caregiver and patient journey. #MakingPeopleSmile #RareDiseaseDay #LightUpForRare #ShowYourStripes #EURORDIS
-
-
Everyone should have a chance to live life to the fullest. This #RareDiseaseDay, Kyowa Kirin joins the rare community in advocating for equitable access to timely diagnosis, treatment, and care for people living with rare diseases. #RareDiseaseDay #ShareYourRare #ShowYourStripes #ShowYourColours
-
-
Finding strength in community can help when navigating the challenges of life with a #raredisease. When Sophia was diagnosed with #XLH, her mom knew she needed help. Thanks to support from the community, they no longer feel alone on their journey. #ShowYourStripes #RareDiseaseMonth
-
During the month of February, at Kyowa Kirin we are focused on supporting the rare disease community in its efforts to amplify awareness. Abdul Mullick, Chief International Business Officer and Managing Executive Officer, Kyowa Kirin, shares what equity in care and opportunity means to him. Read his personal post below. #MakingPeopleSmile #RareDiseaseDay #LightUpForRare #ShowYourStripes #EURORDIS
Equity is not just a goal; it’s a responsibility. For the rare disease community, equity in care and opportunities means so much more than medical access – it’s about living full, empowered lives. Together, we can create a world where everyone impacted by a rare disease has fair access to: ????????????????Comprehensive care networks that address their unique needs. ????????????????Inclusive educational, workplace, and societal opportunities. ????????????????A voice at the table in decisions that affect their lives. This Rare Disease Month, let’s reimagine equity together. Let’s help remove barriers and work to create policies that will allow all patients equitable access to diagnosis, care, and the resources needed for the best possible health outcomes. Because equity is about justice, dignity, and possibility for all. #MakingPeopleSmile #RareDiseaseDay #LightUpForRare #ShowYourStripes #EURORDIS
-
-
Did you know that there are over 6,000 distinct rare conditions, currently affecting about 300 million people worldwide and it takes approximately five years on average for rare disease patients to get a diagnosis? At Kyowa Kirin, we engage with and listen closely to our external environment, so as we approach #RareDiseaseDay, we wanted to shine a light on the stories of those affected by rare diseases. #RareDiseaseMonth
-
During the month of February, Kyowa Kirin is focused on supporting the rare disease community in its efforts to amplify awareness. Read what Jeremy Morgan, President, Kyowa Kirin International plc., shares below on the importance of equity in treatment to him. https://bit.ly/4i2MhDZ
-
What does it take to have a successful career at Kyowa Kirin? Kelli Shannon shares tips that have served her well on her professional journey. Find your next great job: https://bit.ly/3RxoAI4 #Careers #TeamKyowaKirin
-
-
Read what Richard Wilson, our North America Rare Disease Head, has to say about the importance of equitable access to early testing, treatment and diagnosis for rare disease patients below.
Richard Wilson on LinkedIn: #kkmakingpeoplesmile #rarediseaseday #showyourstripes #lightupforrare...
linkedin.com
-
Cutaneous T-cell lymphoma (#CTCL) is a rare form of blood cancer that impacts the skin. Learn more about this disease that is diagnosed in 3,000 Americans per year: https://bit.ly/3EBtRvy #RareDiseaseMonth #LookDeeperAtCTCL